四环医药(00460)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00460 四环医药

交易中 11-19 11:41:12

0.690

+0.000

0.00%

最高0.700	最低0.680	成交量200.90万
今开0.690	昨收0.690	日振幅2.90%
总市值64.31亿	流通市值64.31亿	总股本93.20亿
成交额138.52万	换手率0.02%	流通股本93.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00460","market":"HK","secType":"STK","nameCN":"四环医药","latestPrice":0.69,"timestamp":1731987460164,"preClose":0.69,"halted":0,"volume":2009000,"delay":0,"floatShares":9319999206,"shares":9319999206,"eps":-0.0062507777,"marketStatus":"交易中","marketStatusCode":2,"change":0,"latestTime":"11-19 11:41:12","open":0.69,"high":0.7,"low":0.68,"amount":1385170,"amplitude":0.028986,"askPrice":0.69,"askSize":942000,"bidPrice":0.68,"bidSize":2041000,"shortable":3,"etf":0,"ttmEps":-0.004401365117039158,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1731988800000},"adr":0,"adjPreClose":0.69,"dividendRate":0.029642,"openAndCloseTimeList":[[1731979800000,1731988800000],[1731992400000,1732003200000]],"volumeRatio":0.140044,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00460","defaultTab":"news","newsList":[{"id":"2483319822","title":"四环医药盘中异动 下午盘快速跳水5.63%报0.670港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483319822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483319822?lang=zh_cn&edition=full","pubTime":"2024-11-15 14:51","pubTimestamp":1731653466,"startTime":"0","endTime":"0","summary":"2024年11月15日下午盘14时51分，四环医药股票出现异动，股价大幅下挫5.63%。截至发稿，该股报0.670港元/股，成交量2535.3万股，换手率0.27%，振幅7.04%。资金方面，该股资金流入485.152万港元，流出1221.37万港元。四环医药股票所在的药品行业中，整体跌幅为0.11%。同时，海南四环与阳光人寿签订股权转让协议，海南四环同意以约3.08亿元进一步收购轩竹生物约3.6177%股权。截至目前，XZP-3621治疗 ALK 阳性晚期非小细胞肺癌患者有效性和安全性的三期临床正在进行中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115145107a239f8cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115145107a239f8cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","BK1593","BK1600","00460"],"gpt_icon":0},{"id":"2483319577","title":"四环医药(00460)下跌5.63%，报0.67元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483319577","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483319577?lang=zh_cn&edition=full","pubTime":"2024-11-15 14:51","pubTimestamp":1731653466,"startTime":"0","endTime":"0","summary":"11月15日，四环医药(00460)盘中下跌5.63%，截至14:51，报0.67元/股，成交1765.54万元。四环医药控股集团有限公司是中国处方药市场的领先制药企业，主要业务为生产和销售心脑血管处方药物，自2007年起一直是全国最大的心脑血管处方药物供应商。公司的关键经营数据包括独特的销售模式、全国覆盖的销售网络、多元化的产品组合以及强大的研发能力。截至2024年中报，四环医药营业总收入9.5亿元、净利润-3342.4万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/15145145332044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["00460","BK1593","BK1515","BK1600","BK1191"],"gpt_icon":0},{"id":"2483025167","title":"四环医药，拟分拆轩竹生物在香港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2483025167","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483025167?lang=zh_cn&edition=full","pubTime":"2024-11-13 13:33","pubTimestamp":1731475980,"startTime":"0","endTime":"0","summary":"　　11月12日，四环医药公布，建议分拆轩竹生物的股份并于联交所主板上市，且公司已取得联交所关于其根据上市规则第15项应用指引建议分拆轩竹生物的批准。　　该公司附属海南四环昨日同意以总代价约3.08亿元人民币，向阳光人寿收购轩竹生物约3.6177%股权。　　轩竹生物，于2024年5月24日终止A股上市，根据其2023年3月1日的招股书上会稿，四环医药当时持有轩竹生物62.3892%的股权。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2024-11-13/doc-incvxars2376340.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2024-11-13/doc-incvxars2376340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK1593","BK1191","BK1600","00460"],"gpt_icon":0},{"id":"2483809741","title":"【港股通】四环医药(00460)盘初涨4.23% 拟分拆轩竹生物的股份并在联交所主板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2483809741","media":"金吾财讯","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483809741?lang=zh_cn&edition=full","pubTime":"2024-11-13 09:39","pubTimestamp":1731461994,"startTime":"0","endTime":"0","summary":"金吾财讯 | 四环医药(00460)盘初走强，截至发稿，涨4.23%，报0.74港元，成交额520万港元。消息面上，公司宣布，建议分拆轩竹生物的股份并于联交所主板上市，已取得联交所批准。于11月12日，该公司附属公司海南四环同意以总代价约3.08亿元人民币，进一步收购轩竹生物约3.6177%股权。","market":"nz","thumbnail":"https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947601","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","HSTECH","BK1593","BK1515","BK1191","HSCEI","YANG","00460"],"gpt_icon":0},{"id":"2483092391","title":"港股异动 | 四环医药(00460)早盘涨超4% 计划分拆轩竹生物的股份并在联交所主板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2483092391","media":"智通财经","labels":["Company Corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483092391?lang=zh_cn&edition=full","pubTime":"2024-11-13 09:31","pubTimestamp":1731461489,"startTime":"0","endTime":"0","summary":"消息面上，四环医药发布公告，该公司建议分拆轩竹生物的股份并于联交所主板上市，且该公司已取得联交所关于该公司根据上市规则第15项应用指引建议分拆轩竹生物的批准。于2024年11月12日，海南四环与阳光人寿订立本次股权转让协议，海南四环同意以总代价约人民币3.08亿元进一步收购轩竹生物约3.6177%股权。因此决定于轩竹生物拟议在联交所主板申请上市之际，进行本次收购。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1210188.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1600","BK1593","BK1515","BK1191","00460"],"gpt_icon":0},{"id":"2483092176","title":"四环医药拟分拆轩竹生物并收购股权，总代价5.96亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483092176","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483092176?lang=zh_cn&edition=full","pubTime":"2024-11-13 09:17","pubTimestamp":1731460624,"startTime":"0","endTime":"0","summary":"董事会相信，此次分拆将有助于轩竹生物独立发展，并增强其融资能力，支持业务增长及产业化发展。轩竹生物截至2024年6月30日的净资产为10.3亿元，资产总额为12.5亿元。文章来源：财中社四环医药拟分拆轩竹生物并收购股权，总代价5.96亿元","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113093659a231f537&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113093659a231f537&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1600","00460","BK1191","BK1593","BK1515"],"gpt_icon":0},{"id":"2483096731","title":"【湾区早参】香港9月商品整体出口货量按年升1.2%；澳门9月新批核住宅按揭贷款环比增加142.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483096731","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483096731?lang=zh_cn&edition=full","pubTime":"2024-11-13 08:32","pubTimestamp":1731457960,"startTime":"0","endTime":"0","summary":"经季节性调整，第3季商品整体出口货量按季下跌3.1%，而商品进口货量则上升2.3%。期内，集团收入10.9亿元，同比减少4.49%。首三季度，累计总收入2.9亿美元，增加44.3%。亏损由上年同期2.39亿美元，收窄至1.75亿美元，每股亏损18美仙。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/ZjI3MDQ3NzQxODE1.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZjI3MDQ3NzQxODE1.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947587","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","LU1969619763.USD","BK1221","BK1588","BK1600","00460","LU0307460666.USD","00384","BK1191","BK1574","06808","BK1161","BK1583","BK1515","BK1595","00880","LU0588546209.SGD","00839","BK1589","09688","BK1556","BK1500","BK1172","06160","BK1228","BK1593","BK1177","BK1501","BK1584","BK1566"],"gpt_icon":0},{"id":"2483037468","title":"四环医药(00460.HK)建议分拆轩竹生物联交所主板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2483037468","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483037468?lang=zh_cn&edition=full","pubTime":"2024-11-13 02:30","pubTimestamp":1731436200,"startTime":"0","endTime":"0","summary":"四环医药(00460.HK) 公布，建议分拆轩竹生物于联交所主板上市，并已取得联交所确认可以进行建议分拆。同时，公司向阳光人寿进一步收购轩竹生物3.6177%股权，总代价3.08亿人民币。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-12 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220413154450154_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220413154450154_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1396103/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1593","BK1515","00460","BK1600","BK1191"],"gpt_icon":0},{"id":"2482771083","title":"四环医药：计划分拆轩竹生物的股份并在联交所主板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2482771083","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482771083?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:32","pubTimestamp":1731421955,"startTime":"0","endTime":"0","summary":"新京报贝壳财经讯11月12日，四环医药公告，董事会宣布公司计划分拆轩竹生物的股份并在联交所主板上市，并已获得联交所关于建议分拆轩竹生物的批准。同时，海南四环与阳光人寿订立本次股权转让协议，以总价约3.08亿元进一步收购轩竹生物约3.6177%的股权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411123237426069.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411123237426069.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK1593","BK1191","BK1600","00460"],"gpt_icon":0},{"id":"2482710088","title":"四环医药：计划分拆轩竹生物的股份并在联交所主板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2482710088","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482710088?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:22","pubTimestamp":1731421379,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1600","00460","BK1191","BK1593","BK1515"],"gpt_icon":0},{"id":"2482088200","title":"四环医药(00460)拟分拆轩竹生物的股份并于联交所主板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2482088200","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482088200?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:20","pubTimestamp":1731421211,"startTime":"0","endTime":"0","summary":"智通财经APP讯，四环医药 发布公告，该公司建议分拆轩竹生物的股份并于联交所主板上市，且该公司已取得联交所关于该公司根据上市规则第15项应用指引建议分拆轩竹生物的批准。于2024年11月12日，海南四环与阳光人寿订立本次股权转让协议，海南四环同意以总代价约人民币3.08亿元进一步收购轩竹生物约3.6177%股权。因此决定于轩竹生物拟议在联交所主板申请上市之际，进行本次收购。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1210110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1593","BK1191","BK1600","00460"],"gpt_icon":0},{"id":"2482574457","title":"四环医药(00460)出现大手卖出230万股，成交价$0.72，涉资165.6万","url":"https://stock-news.laohu8.com/highlight/detail?id=2482574457","media":"阿斯达克财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482574457?lang=zh_cn&edition=full","pubTime":"2024-11-12 14:05","pubTimestamp":1731391500,"startTime":"0","endTime":"0","summary":"[大手成交]四环医药(00460)在下午02:05出现大手卖出，成交量为230万，成交价为港币$0.72，涉资165.6万。至目前为止，股价无升跌，今日最高价为$0.76，而最低价为$0.72，总成交量为4.44千万股，总成交金额港币$3.28千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV24111211060/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["00460","BK1600","BK1191","BK1515","BK1593"],"gpt_icon":0},{"id":"2482711444","title":"四环医药(00460)上涨5.56%，报0.76元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482711444","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482711444?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:28","pubTimestamp":1731382117,"startTime":"0","endTime":"0","summary":"11月12日，四环医药(00460)盘中上涨5.56%，截至11:28，报0.76元/股，成交2099.76万元。四环医药控股集团有限公司是中国处方药市场的领先制药企业，主要业务为生产和销售心脑血管处方药物，自2007年起一直是全国最大的心脑血管处方药物供应商。公司的关键经营数据包括独特的销售模式、全国覆盖的销售网络、多元化的产品组合以及强大的研发能力。截至2024年中报，四环医药营业总收入9.5亿元、净利润-3342.4万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/12112845181667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["00460","BK1191","BK1600","BK1593","BK1515"],"gpt_icon":0},{"id":"2482711644","title":"四环医药盘中异动 早盘股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482711644","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482711644?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:28","pubTimestamp":1731382116,"startTime":"0","endTime":"0","summary":"2024年11月12日早盘11时28分，四环医药股票出现异动，股价快速拉升5.56%。截至发稿，该股报0.760港元/股，成交量2832.1万股，换手率0.30%，振幅5.56%。四环医药股票所在的药品行业中，整体涨幅为0.33%。其相关个股中，艾美疫苗、凯莱英、四环医药涨幅较大，振幅较大的相关个股有君圣泰医药-B、艾美疫苗、培力农本方，振幅分别为15.65%、9.24%、9.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112112836abb7f66f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112112836abb7f66f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00460","BK1515","BK1191","BK1600","BK1593"],"gpt_icon":0},{"id":"2482792818","title":"南向资金11月11日净卖出四环医药1060.30万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2482792818","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482792818?lang=zh_cn&edition=full","pubTime":"2024-11-12 09:30","pubTimestamp":1731375008,"startTime":"0","endTime":"0","summary":"11月11日，南向资金减持四环医药1060.30万股连续5日减持。截止当日收盘，港股通共持有四环医药81033.30万股，占流通股8.68%。港股通减持金额前五个股分别为中芯国际、吉利汽车、中国海洋石油、招商银行、药明康德。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112093050a22e09fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112093050a22e09fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","BK1593","BK1600","00460"],"gpt_icon":0},{"id":"2481144353","title":"四环医药11月08日遭主力抛售343万元 环比增加233.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481144353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481144353?lang=zh_cn&edition=full","pubTime":"2024-11-08 16:15","pubTimestamp":1731053741,"startTime":"0","endTime":"0","summary":"11月08日, 四环医药股价跌1.35%，报收0.73元，成交金额1806万元，换手率0.26%，振幅2.70%，量比0.83。四环医药今日主力资金净流出343万元，连续3日净流出，上一交易日主力净流出103万元，今日环比增加233.01%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为43.75%，平均跌幅为2.81%。该股近5个交易日上涨1.39%，主力资金累计净流出493万元；近20日主力资金累计净流出2555万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108161558abace6e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108161558abace6e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1600","00460","BK1515","BK1191","BK1593"],"gpt_icon":0},{"id":"2481620169","title":"南向资金11月7日净卖出四环医药1046.00万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2481620169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481620169?lang=zh_cn&edition=full","pubTime":"2024-11-08 09:30","pubTimestamp":1731029408,"startTime":"0","endTime":"0","summary":"11月7日，南向资金减持四环医药1046.00万股连续3日减持。截止当日收盘，港股通共持有四环医药82617.90万股，占流通股8.84%。港股通减持金额前五个股分别为中芯国际、理想汽车-W、融创中国、农夫山泉、中国海洋石油。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108093034ababa25b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108093034ababa25b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","00460","BK1600","BK1515","BK1191"],"gpt_icon":0},{"id":"2481643500","title":"四环医药盘中异动 下午盘股价大跌5.33%报0.710港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481643500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481643500?lang=zh_cn&edition=full","pubTime":"2024-11-06 13:39","pubTimestamp":1730871596,"startTime":"0","endTime":"0","summary":"2024年11月06日下午盘13时39分，四环医药股票出现波动，股价急速跳水5.33%。截至发稿，该股报0.710港元/股，成交量2169.6万股，换手率0.23%，振幅5.33%。资金方面，该股资金流入286.199万港元，流出1142.73万港元。四环医药股票所在的药品行业中，整体跌幅为0.22%。其相关个股中，三爱健康集团、顺腾国际控股、长江生命科技涨幅较大，振幅较大的相关个股有三爱健康集团、德琪医药-B、顺腾国际控股，振幅分别为16.13%、9.41%、7.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110613395798e40c03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110613395798e40c03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00460","BK1600","BK1191","BK1515","BK1593"],"gpt_icon":0},{"id":"2479728482","title":"四环医药盘中异动 下午盘大幅拉升5.56%报0.760港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479728482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479728482?lang=zh_cn&edition=full","pubTime":"2024-10-31 14:09","pubTimestamp":1730354977,"startTime":"0","endTime":"0","summary":"2024年10月31日下午盘14时09分，四环医药股票出现异动，股价大幅拉升5.56%。截至发稿，该股报0.760港元/股，成交量2885.5万股，换手率0.31%，振幅6.94%。资金方面，该股资金流入1020万港元，流出777.891万港元。四环医药股票所在的药品行业中，整体跌幅为0.31%。其相关个股中，德琪医药-B、顺腾国际控股、长江生命科技涨幅较大，振幅较大的相关个股有中生联合、兴科蓉医药、德琪医药-B，振幅分别为12.70%、11.90%、10.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103114093798e3fa04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103114093798e3fa04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","00460","BK1191","BK1515","BK1600"],"gpt_icon":0},{"id":"2479772387","title":"四环医药(00460)上涨5.56%，报0.76元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2479772387","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479772387?lang=zh_cn&edition=full","pubTime":"2024-10-31 14:09","pubTimestamp":1730354976,"startTime":"0","endTime":"0","summary":"10月31日，四环医药(00460)盘中上涨5.56%，截至14:09，报0.76元/股，成交2104.09万元。四环医药控股集团有限公司是中国处方药市场的领先制药企业，主要业务为生产和销售心脑血管处方药物，自2007年起一直是全国最大的心脑血管处方药物供应商。公司的关键经营数据包括独特的销售模式、全国覆盖的销售网络、多元化的产品组合以及强大的研发能力。截至2024年中报，四环医药营业总收入9.5亿元、净利润-3342.4万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/31140944777213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["00460","BK1191","BK1600","BK1593","BK1515"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sihuanpharm.com.cn","stockEarnings":[{"period":"1week","weight":-0.0417},{"period":"1month","weight":-0.0282},{"period":"3month","weight":0.3529},{"period":"6month","weight":0.1735},{"period":"1year","weight":0.0698},{"period":"ytd","weight":0.1022}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.059},{"period":"3month","weight":0.118},{"period":"6month","weight":0.0198},{"period":"1year","weight":0.1216},{"period":"ytd","weight":0.1484}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"四环医药控股集团有限公司是一家从事药品业务的香港投资控股公司。该公司主要在中国从事研发、制造及销售药品。其产品覆盖心脑血管、中枢神经系统、新陈代谢、肿瘤及抗感染领域。其心脑血管产品包括克林澳、安捷利及欧迪美等。其非心脑血管产品包括仁澳、甲硝唑及罗沙替丁等。","yearOnYearQuotes":[{"month":1,"riseRate":0.615385,"avgChangeRate":0.124205},{"month":2,"riseRate":0.571429,"avgChangeRate":0.002117},{"month":3,"riseRate":0.357143,"avgChangeRate":-0.025539},{"month":4,"riseRate":0.538462,"avgChangeRate":0.029608},{"month":5,"riseRate":0.384615,"avgChangeRate":-0.005384},{"month":6,"riseRate":0.538462,"avgChangeRate":-0.006997},{"month":7,"riseRate":0.538462,"avgChangeRate":-0.005865},{"month":8,"riseRate":0.461538,"avgChangeRate":-0.024169},{"month":9,"riseRate":0.153846,"avgChangeRate":-0.057211},{"month":10,"riseRate":0.615385,"avgChangeRate":0.038326},{"month":11,"riseRate":0.5,"avgChangeRate":0.015246},{"month":12,"riseRate":0.461538,"avgChangeRate":-0.010221}],"exchange":"SEHK","name":"四环医药","nameEN":"SIHUAN PHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"四环医药(00460)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供四环医药(00460)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"四环医药,00460,四环医药股票,四环医药股票老虎,四环医药股票老虎国际,四环医药行情,四环医药股票行情,四环医药股价,四环医药股市,四环医药股票价格,四环医药股票交易,四环医药股票购买,四环医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"四环医药(00460)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供四环医药(00460)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}